Clinical Trial Update: A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Completed Phase II trial evaluating modified FOLFOX 6 plus cetuximab as first-line therapy for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Veeda Oncology | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED